Bayesian Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$3.1M |
| 2 |
Rocket Lab Corp
RKLB
|
+$3.06M |
| 3 |
CRWV
CoreWeave
CRWV
|
+$2.71M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$2.48M |
| 5 |
SNDK
Sandisk
SNDK
|
+$2.39M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6M |
| 2 |
TSMC
TSM
|
+$1.56M |
| 3 |
JPMorgan Chase
JPM
|
+$1.29M |
| 4 |
DexCom
DXCM
|
+$954K |
| 5 |
Microchip Technology
MCHP
|
+$940K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.53% |
| 2 | Consumer Discretionary | 12.15% |
| 3 | Healthcare | 11.18% |
| 4 | Communication Services | 10.58% |
| 5 | Financials | 10.49% |
Similar funds
Bayesian Capital Management's Q1 2026 Portfolio in Review
As of Q1 2026, Bayesian Capital Management held 223 positions worth $81.9M, up 88% from $43.6M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Bayesian Capital Management deployed $45.3M of net new capital in Q1 2026, opening 115 new positions and adding to 13 existing holdings. Its largest new stake was Nike: 51,100 shares worth $2.7M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Netflix, an estimated $441K trimmed.
- Bayesian Capital Management's largest Q1 2026 buy was Nike: 51,100 shares worth $2.7M.
- Bayesian Capital Management added most to Meta Platforms (Facebook) in Q1 2026, an estimated $2.11M increase.
- Bayesian Capital Management's biggest Q1 2026 reduction was Netflix, cutting an estimated $441K.
- Bayesian Capital Management fully exited NVIDIA in Q1 2026, selling an estimated $1.6M.
- Bayesian Capital Management's ten largest holdings make up 31% of its $81.9M portfolio in Q1 2026.
- Bayesian Capital Management opened 115 new positions and closed 86 in Q1 2026.
- Bayesian Capital Management's portfolio value rose 88% quarter-over-quarter to $81.9M.
Based on Bayesian Capital Management's 13F filing for Q1 2026, filed 15 May 2026.